Clinical Oncology NewsNew Antibody Promising for Relapsed LymphomaClinical Oncology NewsSan Diego—In the first head-to-head comparison, obinutuzumab (GA101, Genentech) appeared to be more active than rituximab in relapsed CD20-positive indolent B-cel…
Adam Mayes' landlord and close friend revealed to Action News 5 that the suspected kidnapper and murderer recently saw a doctor and could be in need of a heart transplant.
Immune drug doesn't help kids with hard-to-treat kidney disorderEurekAlert (press release)Children with a particular kidney immune disorder that is unresponsive to standard treatments do not benefit from the immune drug rituximab. Additional studie…
MedCity NewsStem Cell Study Shows Promising Results Against Heart FailureU.S. News & World ReportBy Denise Mann THURSDAY, May 10 (HealthDay News) — A new treatment that involves spinning bone marrow stem cells to enhance their healing potential may he…
BUCHAREST, Romania A Romanian baby born with virtually no intestines who confounded doctors by tenaciously clinging to life and captured international attention and offers of medical help, died on Thursday. He was nine months old.
Stem Cell Study Shows Promising Results Against Heart FailureMSN Health & FitnessBy Denise MannHealthDay Reporter THURSDAY, May 10 (HealthDay News) — A new treatment that involves spinning bone marrow stem cells to enhance their healing potential may …
Cell Therapeutics' Pixuvri® Approved in European Union as Monotherapy to Treat …MarketWatch (press release)The EMA's Committee for Medicinal Products for Human Use ("CHMP") has accepted PIX306, CTI's ongoing randomized controll…
OneMedPlaceCompassionate Use of Pluristem's PLX Cells Saves the Life of a Child after …Proactive Investors USA & Canada“With her body rejecting all possible treatment – and with no other options – we finally turned to Pluristem's PLX ce…
Double lung recipient Helene Campbell is back in a Toronto hospital after experiencing shortness of breath. Manon Campbell, Helene's mother, announced the setback in a blog post Wednesday night.
Boston Scientific Announces Schedule For EuroPCR 2012Sacramento BeeEVOLVE is a prospective, randomized, non-inferiority trial that compares two dose formulations of everolimus on Boston Scientific's SYNERGY Coronary Stent System to the PROMUS Eleme…